Toxicities of hypofractionated radiotherapy after breast-conserving surgery: a literature review
10.3760/cma.j.cn113030-20220629-00211
- VernacularTitle:乳腺癌保乳术后大分割放疗的不良反应研究进展
- Author:
Yuchun SONG
1
;
Shulian WANG
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Keywords:
Breast neoplasms;
Breast-conserving surgery;
Radiotherapy;
Radiation dose hypofractionation;
Toxicity
- From:
Chinese Journal of Radiation Oncology
2022;31(12):1179-1184
- CountryChina
- Language:Chinese
-
Abstract:
Hypofractionated radiotherapy, which provides equivalent efficacy and dose not increase toxicity compared with conventional fractionated radiotherapy following breast-conserving surgery, has become a preferred choice for whole breast irradiation. Given the low local recurrence risk and long survival time for early breast cancer survivors, radiation-associated toxicities are the focus of clinical practice. However, in the era of hypofractionated radiotherapy, the risk factors for radiation-associated toxicity remain undefined and further research is warranted. In this review, we aim to provide an overview of the toxicities of hypofractionated radiotherapy following breast-conserving surgery.
